Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

Abroad (travel likely)RecruitingPHASE2

Conditions

Breast Cancer · Quality of Life

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of North Carolina, Chapel Hill, North Carolina, United States
Contact: Study coordinator (Dana Casey, MD) · dana_casey@med.unc.edu · 984-974-0400

Study leads

Dana Casey, MD
Principal Investigator
University of North Carolina, Chapel Hill

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of AVZO-021 in Patients With Advanced Solid Tumors

Advanced Solid Tumor · HR+/HER2- Breast Cancer · HR+, HER2-, Advanced Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

New Haven, United States · Sarasota, United States

A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC

Breast Cancer · Hormone Receptor-positive Breast Cancer · Hormone Therapy

Abroad (travel likely)RecruitingPHASE2

Taipei, Taiwan · Taipei, Taiwan

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Advanced Solid Tumor · Advanced Breast Cancer · Advanced Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Fullerton, United States

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

HR+/HER2- Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Anchorage, United States